Mistletoe

Mistletoe is a plant that grows on other trees. It's not a disease, but it can sometimes be used in alternative medicine. It's important to talk to your doctor before using it, as it can interact with other medications.

Supplement

What people taking Mistletoe report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Mistletoe

What It's For

Mistletoe is a semiparasitic plant: it grows on the branches of trees such as apple, oak, pine and elm, drawing water and nutrients from its host while still making some of its own food. As a health product, it almost always means European mistletoe (Viscum album). That is a different plant from American mistletoe, the holiday decoration sold in the United States. European mistletoe was used for centuries in traditional medicine for seizures, headaches, high blood pressure and menopause symptoms. Today it is promoted mainly as a complementary cancer therapy, meaning something used alongside standard treatment. In parts of Europe, injectable mistletoe extracts are prescribed to people with cancer in the hope of improving quality of life, easing the side effects of chemotherapy or extending survival. It can also be taken by mouth as a dietary supplement, a form that has barely been studied.

What the Evidence Says

Mistletoe is not a proven cancer treatment, and the US Food and Drug Administration (FDA) has not approved it for cancer or any other condition. The US National Center for Complementary and Integrative Health advises that it not be used to treat cancer outside of clinical trials. Many European studies have reported longer survival or better quality of life, but most were small, poorly described or open to bias, partly because people usually knew whether they were receiving the injections. When researchers separate the better-designed trials from the rest, the apparent survival benefit no longer holds up. The clearest recent test was a Swedish trial of 290 people with advanced pancreatic cancer, who received mistletoe or a placebo injection three times a week for nine months alongside their usual care. Mistletoe did not lengthen survival (about eight months in both groups) and did not improve quality of life or body weight. The most consistent signal is for quality of life during chemotherapy, especially in breast cancer, where some trials found people felt better on mistletoe. Reviews disagree about how much of that is real, and studies with stronger methods show smaller effects or none. Laboratory studies show that mistletoe proteins can kill tumor cells and stimulate the immune system, but those findings have not translated into a demonstrated benefit in people. For its traditional non-cancer uses there is no reliable evidence.

Dosage & Administration

Almost all research uses extracts injected under the skin, usually two or three times a week, often over months. Less often, extracts are given into a vein, into a tumor or by mouth. These injectable products, sold under names such as Iscador and Helixor, are not sold as approved drugs in the United States. Mistletoe products are not interchangeable. Their makeup depends on the species of mistletoe, the host tree it grew on, the time of year it was harvested, how it was extracted (some are fermented or made by homeopathic methods) and the manufacturer. A result from one product does not carry over to another. Oral capsules, teas and tinctures sold as supplements are a separate category with very little research and no established dose.

Side Effects

With injected extracts, a red, sore or swollen patch at the injection site is common: in the pancreatic cancer trial, about two in three people on mistletoe had these skin reactions, compared with almost none on placebo. Flu-like symptoms such as fever, chills, headache, nausea and tiredness can also occur, and they tend to be more likely at higher doses. Serious reactions are uncommon. A few severe allergic reactions, including anaphylaxis, have been reported. Trouble breathing, swelling of the face, lips or throat, or hives with faintness after an injection is an emergency that needs a 911 call. A large or spreading reaction at the injection site, or a fever that does not settle, is worth reporting to whoever is giving the injections.

Interactions & Warnings

Raw European mistletoe berries and leaves can cause serious harm when eaten, so homemade teas or preparations from the plant are not a safe substitute for a manufactured extract. American holiday mistletoe is generally much less toxic: in poison center records, most children who swallowed a few berries or leaves had no symptoms, though stomach upset and, very rarely, a seizure have been reported. If a child eats any part of the plant, a poison control center (1-800-222-1222) can advise whether anything needs to be done. Mistletoe is probably unsafe during pregnancy, and little is known about its safety while breastfeeding. People with cancer should tell their oncology team before starting it, because research on how mistletoe combines with chemotherapy, immunotherapy and other cancer medicines is limited, and herbs can interact with medicines in ways that are hard to predict. Choosing mistletoe instead of standard treatment, rather than alongside it, risks losing treatment that works. As with other supplements, oral mistletoe products are not reviewed by the FDA for safety or effectiveness before they are sold, and their contents can vary.

Questions to Ask Your Doctor

  1. 1.Is there any good reason to add mistletoe to my cancer treatment, given what the research shows for my type of cancer?
  2. 2.Could mistletoe interact with my chemotherapy, immunotherapy or other medicines?
  3. 3.Is there a clinical trial of mistletoe I could join instead of using it on my own?
  4. 4.If I am hoping to feel better during treatment, which proven supportive options should I try first?
  5. 5.How would we tell whether mistletoe is helping me or causing side effects?

Last reviewed • Oct 2026

Educational content, not medical advice.